Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

332 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Application Of Bioisosterism In The Judgment Of Inventiveness

    When determining whether the replacement between two groups in a pharmaceutical compound is common knowledge in the art, bioisosterism may generally be considered.
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    Chinese government releases new regulation on human genetic resources

    Anyone who collects, preserves, utilizes or provides China's human genetic resources should comply with the regulations.
    ChinaIntellectual Property
    Spruson & Ferguson Lawyers
    Spruson & Ferguson Lawyers
Article

SIPO Shifts On Data Disclosure Requirement

According to the criticisms, this unique data requirement of SIPO for medical inventions, especially for compound inventions, is not in line with the patent practices in other major jurisdictions.
ChinaIntellectual Property
AnJie Broad Law Firm
AnJie Broad Law Firm
  • Article

    China FDA Clarifies Legal Consequences Of Clinical Trial Data Inspections

    China's recent drug regulatory reform has emphasized that clinical trial data must be authentic and reliable.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China FDA Releases Guideline For Medical Device Registration Studies

    On May 19, 2015, the China Food and Drug Administration ("CFDA") unveiled the Technical Guideline Governing Medical Device Clinical Evaluation ("Guideline").
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    国家知識産権局、2026年全国特許調査を実施へ

    China's National Intellectual Property Administration has launched a comprehensive 2026 nationwide patent survey targeting approximately 13,000 patent holders and 40,000 valid patents across 27 provinces. The survey will examine patent creation, protection, utilization, commercialization rates, infringement cases, high-value compensation, industry-academia collaboration, and overseas patent activities to inform intellectual property policy development.
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    China Compliance Update: Commercial Bribery Risks Remain Very Real In China

    It has been several months since publicity began about aggressive investigations of potential bribery in the pharmaceutical industry in China.
    ChinaFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    China FDA Announces Implementation Scheme To Improve The Drug Approval System

    Following the reform of the drug and device approval system by China's State Council in August, the China Food and Drug Administration ("CFDA") has finally unveiled its implementation policies regarding improvements to the drug approval system ..
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Tightens Advertising Rules For Life Sciences Companies

    This year China's Advertising Law will see its first amendment in two decades.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    Health Care In The Year Of The Ox: Navigating China's Dynamic M&A Market

    Despite the challenges presented by the pandemic, the Chinese health care sector continues to be fertile ground for both inbound and outbound M&A activity.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Winston Taylor
    Winston Taylor
  • Article

    USITC Will Investigate State Support And Pricing Practices By Chinese Biotechnology Firms

    The U.S. International Trade Commission (USITC) announced on February 26, 2026, that it is undertaking a factfinding investigation to examine Chinese state support and pricing...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    Chinese Companies File Record Number Of European Patent Applications In 2021

    In total, EPO recorded 188,600 patent applications from all over the world last year, 4.5 percent more than in the previous year.
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    デンマークのノボネシス社、中国市場での研究開発と知的財産権管理に注力

    デンマークに本拠を置くバイオ技術企業のノボネシス(Novonesis)社は、産業用酵素の世界トップメーカーであるノボザイムズと、乳酸菌スター
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    世界初の「動画MRI」実用化 中国企業、AI技術でリアルタイム撮影

    中国の医療機器メーカー、上海聯影医療科技(ユナイテッド・イメージング・ヘルスケア)はこのほど、世界初となるハイビジョン「撮影」機
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    Updates On China's Advertising Legislation And Enforcement In 2020

    As the direct impact of COVID-19 in China gradually subsides, the government has released the 2020 legislation plans and the working report for the first quarter of 2020.
    ChinaMedia, Telecoms, IT, Entertainment
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    China Compliance Update – Summer 2025

    Anti-corruption has remained an area of focus area for Chinese authorities in the first half of 2025, with major legislative updates and enforcement cases.
    ChinaCriminal Law
    Arnold & Porter
    Arnold & Porter
  • Article

    China Expects Major Changes In Drug Registration And Contract Manufacturing Rules

    The China Food and Drug Administration ("CFDA") recently announced several draft rules, most notably, the Draft Amendment of the Provisions for Drug Registration (also known as the Drug Registration Rules, DRR) and the Draft Administrative Regulations on the Review and Approval of Drug Contract Manufacturing ("Draft Contract Manufacturing Rules), which will significant impact the pharmaceutical industry. The CFDA is soliciting public comments on both Rules through early December, 2013.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China FDA Releases Guidance On Acceptance Of Foreign Medical Device Study Data

    On January 10, 2018, the China Food and Drug Administration announced the implementation of the Technical Guidelines Governing Acceptance of Medical Device Clinical Data from Foreign Studies.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China FDA Solicits Comments on Priority Review Designation Procedure for Devices

    The China Food and Drug Administration ("CFDA") recently proposed a draft circular to address the priority review designation issue for medical devices, namely the Circular Regarding Soliciting Comments Regarding Priority Review Designation Procedure for Medical Devices (CFDA Circular [2016] No.40, the "Circular").
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    观点 | 《医疗器械管理法(草案)》十大亮点快评

    2024年8月28日,国家药监局发布了《医疗器械管理法(草案征求意见稿)》(以下简称"《征求意见稿》")并向社会公开征求意见。这距离2023年9月7日ʌ
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Showing 41–60 of 332 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics